AVLN Stock: Price, Earnings History and SEC Filings
Avalyn Pharma Inc. (AVLN) last traded at $25.63, down 0.31% on the latest session and down 10.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.98 against an analyst estimate of $-1.03, a beat of 4.9%.
$25.63 -0.31%
1 month-10.04%
52-week high$40.17
52-week low$22.24
Volume343,494
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AVLN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $-0.98 | $-1.03 | +4.85% |
| Mar 2026 | Jun 3, 2026 | $-21.83 | $-16.38 | -33.27% |
AVLN beat the analyst EPS estimate in 1 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for AVLN
SEC filing data is not available right now. You can search for AVLN on SEC EDGAR.
AVLN news
- Avalyn Pharma Stock Price HistoryOct 30, 2026 · investing.com
- Avalyn Pharma Inc AVLNOct 29, 2026 · morningstar.com
- Avalyn Pharma Inc. Common Stock (AVLN) EarningsOct 28, 2026 · fxempire.com
About Avalyn Pharma Inc.
Avalyn Pharma Inc. (AVLN) is a US-listed public company on Nasdaq.